Financial Summary (All financials)
| In millions, except per share items | Jan-31-22 | Jan-31-21 | Jan-31-20 | Jan-31-19 |
| Revenues | 474.0 | 443.5 | 457.1 | 433.5 |
| Revenue growth | 6.9% | -3.0% | 5.5% | |
| Cost of goods sold | 132.4 | 132.7 | 164.0 | 176.8 |
| Gross profit | 341.6 | 310.8 | 293.1 | 256.7 |
| Gross margin | 72.1% | 70.1% | 64.1% | 59.2% |
| Selling, general and administrative | 185.9 | 162.6 | 153.9 | 137.3 |
| Research and development | 143.4 | 128.7 | 111.3 | 100.0 |
| EBITA | 13.1 | 20.5 | 30.3 | 26.8 |
| EBITA margin | 2.8% | 4.6% | 6.6% | 6.2% |
| Amortization of intangibles | 2.1 | 2.2 | 3.0 | 8.1 |
| EBIT | 11.0 | 18.3 | 27.3 | 18.7 |
| EBIT margin | 2.3% | 4.1% | 6.0% | 4.3% |
| Pre-tax income | 8.3 | 24.7 | 29.9 | 19.9 |
| Income taxes | 18.5 | 4.4 | 2.6 | 7.6 |
| Tax rate | 224.1% | 17.9% | 8.6% | 38.2% |
| Net income | -14.9 | 14.2 | 20.2 | 8.7 |
| Net margin | -3.1% | 3.2% | 4.4% | 2.0% |
| |
| Diluted EPS | ($0.22) | $0.22 | $0.31 | $0.13 |
| Shares outstanding (diluted) | 66.6 | 65.8 | 65.8 | 65.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|